论文部分内容阅读
目的 :探讨对原发性肝癌经肝动脉化疗栓塞后的疗效及注意事项。方法 :采用Seldinger方法 ,经股动脉穿刺超选择插入供肿瘤血管的主要分支 ,注入化疗药物 ,碘化油及明胶海绵。结果 :αFP降低原来数值 2 0 %占 5 2 %。术后肿瘤缩小超过 3 0 %占42 %。生存率为 :半年 86%,11例为 6～ 12月 ,2例 >12月。结论 :肝动脉化疗栓塞治疗原发性肝癌中、晚期患者是一种姑息疗法。对于减轻症状 ,延长病人生存期不失为一种有效的可行方法。由于原发性肝癌病人常伴有肝硬化、门静脉高压、食道静脉曲张、腹水、黄疸及肝功能损害等并发症 ,严格掌握适应证、规范操作方法、综合治疗原则、注重保护肝功能及提高机体免疫力 ,是提高手术成功率及改善病人症状、延长病人生存期需引起重视的问题
Objective: To investigate the efficacy and precautions after transcatheter arterial chemoembolization of primary hepatic carcinoma. Methods: The Seldinger method was used to insert the chemotherapeutic drugs, iodized oil and gelatin sponge into the main branches of the tumor blood vessels by superselective insertion of femoral artery puncture. Results: αFP decreased 20% of the original value of 52%. Postoperative tumor shrink more than 30% 42%. Survival rates were 86% for six months, 11 for 6-12 months and 2 for> 12 months. Conclusion: Transcatheter arterial chemoembolization in the treatment of primary liver cancer, advanced patients is a palliative treatment. It is an effective and feasible method to relieve symptoms and prolong the survival of patients. Because patients with primary hepatocellular carcinoma are often accompanied by liver cirrhosis, portal hypertension, esophageal varices, ascites, jaundice and complications such as liver dysfunction, strict indications, standardized methods of operation, the principle of comprehensive treatment, focus on the protection of liver function and improve the body Immunity, is to raise the success rate of surgery and improve patient symptoms, prolong the survival of patients need to pay attention to the problem